This randomized , double-blind , placebo-controlled clinical study was performed among @ patients with relapsing-remitting MS. Subjects were randomly assigned to a placebo group ( n = @ ) or coenzyme Q@ ( CoQ@ ) - supplemented group ( @ mg/day , n = @ ) .